Tumour mutational burden (TMB) assessment using next generation sequencing (NGS) for the prediction of complete response (CR) to immunotherapy (IO) in metastatic melanoma

T. G. Humphries, T. Giardina, N. Mesbah Ardakani, M. A. Khattak, Tarek Meniawy, A. Jacques, E. S. Gray, B. Amanuel, M. Millward

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

Original languageEnglish
Article number1053P
Pages (from-to)S879-S879
Number of pages1
JournalAnnals of Oncology
Publication statusPublished - 2021
EventCongress of the European-Society-for-Medical-Oncology (ESMO) -
Duration: 16 Sept 202121 Sept 2021

Cite this